心脏骤停转运患者终止复苏规则的成本效果比较
该经济分析从NHS与个人社会服务(PSS)视角、终身时间 horizon,比较院外心脏骤停(OHCA)转运患者不同终止复苏(TOR)规则的成本效果。系统评价识别出33条TOR规则,经济分析评估了其中29条加当前实践;结局数据来自OHCAO结局登记、试验数据与已发表文献。最具有成本效果的策略为ERC TOR规则(ICER 8,111英镑)、KOC 2 TOR规则(ICER 17,548英镑)和通用BLS TOR规则(ICER 19,498,216英镑);KOC 2规则在每QALY 20,000–30,000英镑的既定成本效果阈值内具有成本效果。作者认为需进一步研究TOR规则的经济影响,以支持实施TOR规则的建设性讨论。
要点
- 经济分析评估29条TOR规则加当前实践,ERC TOR规则ICER为8,111英镑。
- KOC 2 TOR规则ICER为17,548英镑,在每QALY 20,000–30,000英镑阈值内具有成本效果。
- 通用BLS TOR规则ICER为19,498,216英镑。
- 系统评价共识别33条TOR规则,数据来自OHCAO结局登记、试验数据与已发表文献。
- 作者认为需进一步研究TOR规则的经济影响,以支持实施TOR规则的建设性讨论。
适用人群与场景
- 转运中的院外心脏骤停(OHCA)患者。
研究设计与关键结果
- 研究类型:经济分析(成本效果分析),从NHS与PSS视角、终身时间 horizon,估算贴现的NHS与PSS成本和质量调整生命年(QALYs),计算增量成本效果比(ICERs)。
- 系统评价识别33条TOR规则;经济分析评估其中29条TOR规则加当前实践。
- 数据来源:OHCAO结局登记、试验数据与已发表文献。
- 最具有成本效果的策略:ERC TOR规则ICER 8,111英镑;KOC 2 TOR规则ICER 17,548英镑;通用BLS TOR规则ICER 19,498,216英镑。
- KOC 2 TOR规则在每QALY 20,000–30,000英镑的既定成本效果阈值内具有成本效果。
证据类型、等级与局限
- 证据类型:经济分析(成本效果分析),基于系统评价识别的TOR规则及OHCAO结局登记、试验数据与已发表文献。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为需进一步研究TOR规则的经济影响,以支持实施TOR规则的建设性讨论。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIM: To compare the cost-effectiveness of termination-of-resuscitation (TOR) rules for patients transported in cardiac arrest.
METHODS: The economic analyses evaluated cost-effectiveness of alternative TOR rules for OHCA from a National Health Service (NHS) and personal social services (PSS) perspective over a lifetime horizon. A systematic review was used to identify the different TOR rules included in the analyses. Data from the OHCAO outcomes registry, trial data and published literature were used to compare outcomes for the different rules identified. The economic analyses estimated discounted NHS and PSS costs and quality-adjusted life-years (QALYs) for each TOR rule, based on which incremental cost-effectiveness ratios (ICERs) were calculated.
RESULTS: The systematic review identified 33 TOR rules and the economic analyses assessed the performance of 29 of these TOR rules plus current practice. The most cost-effective strategies were the European Resuscitation Council (ERC) termination of resuscitation rule (ICER of £8,111), the Korean Cardiac Arrest Research Consortium 2 (KOC 2) termination of resuscitation rule (ICER of £17,548), and the universal Basic Life Support (BLS) termination of resuscitation rule (ICER of £19,498,216). The KOC 2 TOR rule was cost-effective at the established cost-effectiveness threshold of £20,000-£30,000 per QALY.
CONCLUSION: The KOC 2 rule is the most cost-effective at established cost-effectiveness thresholds used to inform health care decision-making in the UK. Further research on economic implications of TOR rules is warranted to support constructive discussion on implementing TOR rules.
参考来源
- Khan KA, Petrou S, Smyth M, et al. Comparative cost-effectiveness of termination of resuscitation rules for patients transported in cardiac arrest. Resuscitation. 2024. PMID: 38879073. doi:10.1016/j.resuscitation.2024.110274
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。